GRANULES INDIA LIMITED
Regd Office : 2nd Floor, 3rd Block, My Home Hub
Madhapur, Hyderabad 500 081
UNAUDITED FINANCIAL RESULTS 
FOR THE QUARTER  ENDED 31st DECEMBER, 2007
Rs. Lakhs
S No Particulars Quarter ended             31st Dec 2007 Quarter ended             31st Dec 2006 Half-year ended             31st Dec 2007 Half-year ended             31st Dec 2006  Audited previous accounting year ended 30th June 2007 
1 Gross sales        5,536.73         5,323.39         10,837.22        10,112.92            19,519.33
  Less : Excise Duty & Sales tax           242.55           302.36              539.99             553.09                 949.23
2 Net sales/ Income from operations        5,294.18         5,021.03         10,297.23          9,559.83            18,570.10
3 Other Income             99.35             73.90                64.69               69.36                 246.31
4 Total expenditure          
  a) (Increase)/decrease in stock in trade            (65.85)          (336.69)             (119.96)            (519.88)                   13.23
  b) Material consumption        3,134.30         3,293.00           6,066.86          6,068.16            10,720.73
  c) Manufacturing expenses           469.16           393.12              867.58             769.36              1,588.94
  d) Employee cost           372.16           293.40              725.31             594.64              1,200.97
  e) Other expenditure           639.63           546.87           1,201.66          1,043.72              1,923.29
5 EBIDTA (2-4)           744.78           831.33           1,555.78          1,603.83              3,122.94
6 Interest and finance charges           292.18           316.96              560.66             626.83              1,202.85
7 Depreciation           235.57           209.03              468.03             416.91                 817.73
8 Profit before taxation            316.38           379.24              591.78             629.45              1,348.67
9 Current tax expense              32.02             10.80                58.15               12.65                   43.93
10 Deferred tax expense             53.06             61.83                97.74             104.52                 283.65
11 Fringe Benefit  Tax                2.74               2.02                 5.39                4.06                    9.11
12 Net Profit           228.56           304.59              430.50             508.22              1,011.98
13 Paid up share capital        2,005.72         1,238.06           2,005.72          1,238.06              2,002.36
   (face value of Rs. 10/- each)          
14 Reserves excluding Revaluation reserve                     15,262.42
15 Basic Earnings per share (Rs.)*               1.14               2.46                 2.15                4.10                    7.63
16 Diluted Earnings per share (Rs.)*               1.06               2.22                 1.99                3.70                    6.81
17 No. of equity shares     20,057,154     12,380,572        20,057,154       12,380,572           20,023,634
18 Aggregate of Public Share holding:          
   - Number of shares     13,709,123       7,000,132        13,709,123        7,000,132           13,670,603
   - Percentage of share holding 68.35% 56.54% 68.35% 56.54% 68.27%
* Not Annualised for quarter ending
NOTES :
1) The above  results have been approved at the  Board Meeting held  on 24th January, 2008 and were subjected to 
      limited review by Statutory Auditors.
2) The company has not received any complaints from investors during the quarter 1st October '07 to 31st December'07
     and no complaints were pending from previous quarter.
3) The company operates only in the segment of Pharmaceuticals.
4) Diluted EPS includes 16,00,000 share warrants which are yet to be converted.
5)  Figures are regrouped wherever necessary.
for and on behalf of the Board
Place  : Hyderabad         Dr.C.Nageswara Rao
Date   :  24.01.2008                 Chairman